Martine Ropert Selected Research

Martine Ropert Research Topics

Disease

25	Iron Overload 01/2022 - 06/2002
13	Hemochromatosis (Bronze Diabetes) 01/2021 - 01/2002
5	Anemia 01/2022 - 12/2011
5	Fibrosis (Cirrhosis) 04/2016 - 09/2009
3	Atrophy 01/2022 - 01/2016
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 04/2010
3	Neoplasms (Cancer) 01/2021 - 07/2005
3	Inflammation (Inflammations) 10/2019 - 01/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 05/2018
2	Hemolysis 09/2021 - 11/2020
2	Insulin Resistance 11/2019 - 05/2013
2	Thalassemia 10/2011 - 04/2010
2	Liver Diseases (Liver Disease) 03/2011 - 05/2004
2	Liver Failure 06/2005 - 05/2004
2	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 06/2005 - 05/2004
1	Psychotic Disorders (Schizoaffective Disorder) 01/2022
1	Diabetes Mellitus 01/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Parkinsonian Disorders (Parkinsonism) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	COVID-19 01/2022
1	Poisoning 01/2022
1	Megaloblastic Anemia 09/2021
1	Chronic Renal Insufficiency 09/2021
1	Thrombocytopenia (Thrombopenia) 09/2021
1	Muscular Atrophy (Muscle Atrophy) 01/2021
1	Hyperferritinemia 05/2017
1	Hyperuricemia 05/2017
1	Necrosis 01/2016
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2015
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 03/2014
1	Autosomal Dominant Iron Overload 11/2013
1	Overweight 05/2013
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2011
1	Hepatolenticular Degeneration (Wilson's Disease) 05/2004
1	Siderosis 05/2004
1	Chronic Disease (Chronic Diseases) 06/2002

Drug/Important Bio-Agent (IBA)

35	IronIBA 01/2022 - 01/2002
15	HepcidinsIBA 01/2022 - 07/2005
13	Transferrin (beta 2 Transferrin)IBA 01/2022 - 06/2002
6	Ferritins (Ferritin)IBA 01/2022 - 12/2011
4	Ceruloplasmin (Ferroxidase)IBA 12/2019 - 01/2002
4	Chelating AgentsIBA 08/2015 - 04/2010
3	Familial apoceruloplasmin deficiencyIBA 01/2022 - 06/2002
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2004
3	MetalsIBA 01/2021 - 08/2015
3	Messenger RNA (mRNA)IBA 10/2019 - 07/2005
2	metal transporting protein 1 (ferroportin)IBA 01/2022 - 04/2011
2	Biological ProductsIBA 09/2021 - 01/2019
2	thermozymocidin (myriocin)IBA 11/2019 - 01/2016
2	CeramidesIBA 11/2019 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2012 - 06/2005
2	Deferasirox FDA Link 10/2011 - 04/2010
1	Growth Differentiation Factor 15IBA 01/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 09/2021
1	Metformin (Glucophage)FDA LinkGeneric 09/2021
1	Dietary IronIBA 01/2021
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2021
1	IsotopesIBA 01/2021
1	BilirubinIBA 11/2020
1	MyoglobinIBA 11/2020
1	Insulin (Novolin)FDA Link 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 11/2019
1	Glucose Transporter Type 4IBA 11/2019
1	MolybdenumIBA 10/2019
1	CopperIBA 10/2019
1	ManganeseIBA 10/2019
1	ZincIBA 10/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2017
1	AntioxidantsIBA 05/2017
1	Uric Acid (Urate)IBA 05/2017
1	CreatinineIBA 04/2016
1	Cystatin CIBA 04/2016
1	SphingolipidsIBA 01/2016
1	Transaminases (Aminotransferases)IBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 10/2015
1	PolyaminesIBA 08/2015
1	Hemochromatosis ProteinIBA 03/2014
1	Biomarkers (Surrogate Marker)IBA 05/2013
1	EnzymesIBA 10/2011
1	Alanine Transaminase (SGPT)IBA 04/2011
1	Ethanol (Ethyl Alcohol)IBA 03/2011
1	DeferiproneIBA 04/2010
1	Transferrin Receptors (Transferrin Receptor)IBA 09/2007

Therapy/Procedure

2	Bloodletting 01/2021 - 10/2015
2	Liver Transplantation 03/2014 - 07/2005
1	Erythrocyte Transfusion 01/2022
1	Chelation Therapy (Therapy, Chelation) 10/2011
1	Therapeutics 03/2010
1	Subcutaneous Infusions 06/2002